Showing results (2321-2330 of 2,628) with videos related to
Sort By:
Pageof 263
Journal of Alzheimer'S Disease : JAD|June 4, 2019
Gamma Band Light Stimulation in Human Case Studies: Groundwork for Potential Alzheimer's Disease TreatmentMarggie Jones, Barry McDermott, Bárbara Luz Oliveira, et al.Journal of Primary Health Care|September 5, 2012
Addressing patient alcohol use: a view from general practiceThomas Mules, Jennifer Taylor, Rachel Price, et al.The British Journal of Dermatology|January 25, 2023
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort studyAli Al-Janabi, Amelle Ra, Zoe Littlewood, et al.Circulation|November 3, 2025
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE TrialRobert A Lookstein, Stavros V Konstantinides, Ido Weinberg, et al.Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 2025
Paleobiome dynamics shaped a large Gondwanan plant radiationAlexander Skeels, Hervé Sauquet, Austin Mast, et al.Drugs & Aging|May 6, 2024
Measuring Quality of Life in Deprescribing Trials: A Scoping ReviewWade Thompson, Carina Lundby, Adam Bleik, et al.Journal of Clinical Lipidology|March 21, 2020
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.Biorxiv : the Preprint Server for Biology|October 9, 2023
Target gene regulatory network of miR-497 in angiosarcomaAnnaleigh Benton, Emma Terwilliger, Noah M Moriarty, et al.European Cells & Materials|February 1, 2020
Deriving a dose and regimen for anti-glucosaminidase antibody passive-immunisation for patients with Staphylococcus aureus osteomyelitisC C Lee, R D Southgate, C Jiao, et al.Pageof 263